Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Incyte Corporation
M.D. Anderson Cancer Center
University of Washington
Incyte Corporation
Takeda
NS Pharma, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Novartis
Mayo Clinic
Italfarmaco
Incyte Corporation
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center